@article{e9b9a52dfca94f8eb5b0537199650000,
title = "GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders",
abstract = "Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.",
keywords = "Humans, Diabetes Mellitus, Type 2, Ethanol, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptide-1 Receptor Agonists, Substance-Related Disorders/drug therapy",
author = "Lorenzo Leggio and Hendershot, {Christian S} and Mehdi Farokhnia and Anders Fink-Jensen and Klausen, {Mette Kruse} and Schacht, {Joseph P} and Simmons, {W Kyle}",
year = "2023",
month = dec,
doi = "10.1038/s41591-023-02634-8",
language = "English",
volume = "29",
pages = "2993--2995",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Research",
number = "12",
}